Investor Relations contact: LifeSci Advisors, LLC. Hans Vitzthum, Managing Director 1 International Place, Suite 1480. Boston, MA 02110. Phone: (617) 430-7578
May 20, 2021 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
AzurRx BioPharma Inc (US:AZRX) has 0 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
Mar 12, 2021 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Investor Relations contact: LifeSci Advisors, LLC. Hans Vitzthum, Managing Director 1 International Place, Suite 1480. Boston, MA 02110. Phone: 617-430-7578
Dec 1, 2017 · In this analysis, my focus will be on developing a perspective on AzurRx BioPharma Inc's (NASDAQ:AZRX) latest ownership structure, ...
Discover real-time First Wave BioPharma, Inc. Common Stock (FWBI) stock prices, quotes, historical data, news, and Insights for informed trading and ...
Jul 20, 2020 · Investor Relations contact: LifeSci Advisors, LLC. Hans Vitzthum, Managing Director 1 International Place, Suite 1480. Boston, MA 02110. Phone ...
Apr 21, 2020 · Investor Relations contact: LifeSci Advisors, LLC. Hans Vitzthum, Managing Director 1 International Place, Suite 1480. Boston, MA 02110. Phone ...
Ambrx is advancing a focused portfolio of clinical and preclinical programs designed to optimize efficacy and safety in multiple cancer indications, including ...
Missing: azrx | Show results with:azrx